期刊文献+

过氧化物酶体增殖物激活受体δ+294T/C基因多态性与冠心病的关系 被引量:1

Relationship of peroxisome proliferation-activated receptor-delta+294T/C gene polymorphism with coronary artery disease
下载PDF
导出
摘要 目的探讨过氧化物酶体增殖物激活受体δ(PPARδ)+294T/C基因多态性与冠心病的关系。方法运用聚合酶链式反应及限制酶切片段长度多态性技术分析无血缘关系汉族人群[82例正常对照者(NC),120例冠心病(CHD)患者]的PPARδ+294T/C基因多态性,分析基因型频率、等位基因频率,并对不同基因型患者冠心病的危险性进行评价。结果两组间基因型分布有显著性差异(P<0.05);CHD组TC+CC基因频率及C等位基因频率均明显高于NC组(P<0.05);C等位基因携带(TC+CC)者冠心病危险性高于TT基因型(C等位基因携带者OR:3.16,95%CI:1.39~7.14)。结论PPARδ+294T/C基因多态性与冠心病之间有重要的相关性,C等位基因携带可能是冠心病的一个的危险因素。 Objective To investigate the relationship of peroxisome proliferation-activated receptor-delta (PPARδ) + 294T/C gene polymorphisms with coronary heart disease (CHD). Methods 202 kinless subjects of the Chinese Han were investigated in this study, including 82 normal controls(NC) and 120 cases diagnosed as CHD. PPARδ + 294T/C gene polymorphisms were determined by polymerase chain reaction and restriction fragment length polymorphisms. The frequencies of PPARδ + 294T/C genotypes and the "C" allele frequency were analyzed, to evaluate the risk of the CHD among variant genotypes. Results The genotype distribution was significantly different between the CHD and the NC (P 〈 0.05 ). The frequencies of TC + CC genotype and "C" allele were eridently higher in the CHD group than in the NC, the CHD risk of the" C" allele carriers was significantly higher than that of the TT homozygote ( "C" allele OR : 3.16,95 % CI: 1.39 - 7. 14 ). Conclusion There is evident association between PPARδ + 294T/C gene polymorphisms and CHD. The "C" allele may be a risk factor of CHD.
出处 《安徽医科大学学报》 CAS 北大核心 2008年第6期701-705,共5页 Acta Universitatis Medicinalis Anhui
关键词 冠状动脉疾病 多态性 限制性片段长度 PPAR8 coronary disease polymorphism, restriction fragment length PPAR delta
  • 相关文献

参考文献14

  • 1Fruchart J C, Duriez P, Staels B. Peroxisome proliferators-activated receptor-alpha activators regulate genes governing liporprotain metabolism, vascular inflammation and atherosclerosis [ J ]. Curr Opin Lipidol, 1999, 10(3) :245 -57.
  • 2高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:4901
  • 3Gouni-Berthod I, Giannakdou E, Faust M, et al. The peroxisome proliferator- activated receptor + 294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type2 and in non-diabetic controls [ J ]. Atherosclerosis, 2005,183 (2) : 336 -41.
  • 4Skogsberg J, Kannisto K, Cassel T N, et al. Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men [ J ]. Arterioscler Thromb Vase Biol, 2003,23 (4) :637 -43.
  • 5Barish G D, Narkae V A, Evans R M. PPARδa dagger in the heart of the metabolic syndrome [ J ]. J Clin Invest,2006, 116 ( 3 ) : 590 - 7.
  • 6Aberle J, Hopfer I, Beil F U, et al. Association of the T +294C polymorphism in PPAR delta with low HDL cholesterol and coronary heart disease risk in women[J]. Int J Med Sci, 2006,3(3) : 108 11.
  • 7Chen S, Tsybouleva N, Ballantyne C M, et al. Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study [ J ]. Pharmacogenetics, 2004,14( 1 ) :61 -71.
  • 8Skogsberg J, Kannisto K, Roshani L,et al. Characterization of the human peroxisome proliferators activated receptor delta gene and its expression [J].Int J Mol Med,2000,6 ( 1 ) :73 - 81.
  • 9Skogsberg J, MeMahon A D, Karpe F, et al. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men [J].J. Intern Med,2003,254 (6) :597 - 604.
  • 10Shin H D,Park B L,Kim L H,et al. Genetic polymorphisms in peroxisome proliferator- activated receptor -δ associated with obesity [ J ]. Diabetes,2004,53 ( 3 ) : 847 - 51.

二级参考文献22

  • 1祝之明,周芳明,张刚,赵志钢,倪银星,祝善俊.代谢综合征心血管重塑的特征[J].中华心血管病杂志,2004,32(9):819-820. 被引量:41
  • 2罗俊,燕纯伯.颈动脉超声对动脉粥样硬化性疾病的研究进展[J].心血管病学进展,2005,26(1):1-4. 被引量:84
  • 3无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2052
  • 4De′Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adulrs: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol, 1992, 20:1251-1260.
  • 5Palmieri V, Bella JN,Arnett DK,et al. Effect of type 2diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects.Circulation,2001,103:103-107.
  • 6Bella JN,Deverux RB,Roman MJ,et al. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians(The strong heart study).Am J Cardio,2001,87:1260-1265.
  • 7Vohl MC,Lepage P,Gaudet D,et al. Molecular scaning of the human PPARα gene:association of the L162V mutation with hyperapobetalipoproteinemia. J Lipid Res,2000,41:945-952.
  • 8Esparragon FJR, Perez JCR, Reyes AM,et al.Peroxisome proliferator activated receptor gamma2-pro12Ala and endothelial nitric oxide synthase 4a/b gene polymorphism are associated with essential hypertension. J Hypertens,2003,21:1649-1655.
  • 9Ostgren CJ, Lindblad U, Melander O, et al.Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: Skaraborg Hypertension and Diabetes Project. J Hypertens,2003,21:1657-1662.
  • 10Skogsberg J, Kannisto K,Roshani L,et al. Characterization of the human peroxisome proliferator activated receptor delta gene and its expression.Int J Mol Med,2000,6:73-81.

共引文献4916

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部